CHARLOTTE, NC--(Marketwired - Apr 22, 2015) - BSN medical, a leading global medical device manufacturer, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned two ...

Bioretec Ltd, a pioneer in absorbable orthopedic implants, was granted Transitional Pass-Through Payment (TPT) status by the U.S. Centers for Medicare & Medicaid Services (CMS) for its RemeOs™ Trauma ...

GOLDEN VALLEY, Minn.--(BUSINESS WIRE)--Preceptis Medical, Inc. announced today that the Centers for Medicare & Medicaid Services (CMS) has finalized the creation of a new add-on G code to identify and ...

FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and ...

Nationally Established Q Code Will Further Support the Use of Biovance® 3L by Physicians to Treat Wound Care Patients in Office Settings FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- ...

FORT WORTH, Texas, April 12 /PRNewswire/ -- HEALTHPOINT announced that as of January 1, 2006 the American Medical Association has released two new Current Procedural Terminology (CPT)(R) Codes that ...

FRAMINGHAM, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, ...

CMS has announced it will begin reimbursing for four new Q codes effective for claims with dates of service on or after July 1. The new codes have an MPFSDB status indicator of E. CMS also announced ...

SALT LAKE CITY , Sept. 13, 2024 /PRNewswire/ -- Matia Mobility (https://www.matiamobility.com), a leader in durable medical equipment, is proud to announce that the Centers for Medicare & Medicaid ...

BSN medical, a leading global medical device manufacturer, has announced that the Centers for Medicare and Medicaid Services (CMS), has assigned two Healthcare Common Procedure Coding System (HCPCS) ...

Nationally Established Q Code Will Further Support the Use of Biovance® 3L by Physicians to Treat Wound Care Patients in Office Settings FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- ...

MELBOURNE, Australia, July 9, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that its next-generation PSMA[1] PET[2] imaging agent, Gozellix® (kit ...